ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,305Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 617

$496K Total Retail Price of All Prescriptions

Rank: 103 out of 617

379 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 379 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,385 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 311 267 1 2
OMEPRAZOLE 284 220 2 3
LEVOTHYROXINE SODIUM 275 230 3 1
HYDROCODONE-ACETAMINOPHEN 220 95 S3 4 8
LISINOPRIL 214 175 5 5
HYDROCHLOROTHIAZIDE 205 189 6 13
TRAMADOL HCL 181 154 7 15
METFORMIN HCL 165 151 8 9
FUROSEMIDE 152 122 9 4
ATORVASTATIN CALCIUM 150 132 10 14
AMLODIPINE BESYLATE 149 141 11 6
METOPROLOL SUCCINATE 149 116 11 12
WARFARIN SODIUM 129 123 13 7
GABAPENTIN 120 85 14 16
BENAZEPRIL HCL 114 90 15 44
TRIAMTERENE-HCTZ 101 88 16 47
ALENDRONATE SODIUM 100 92 17 25
PRAVASTATIN SODIUM 100 85 17 21
ZOLPIDEM TARTRATE 95 66 19 23
SERTRALINE HCL 93 55 20 20
CRESTOR 88 69 21 28
TAMSULOSIN HCL 80 71 22 26
ATENOLOL 77 72 23 17
METOPROLOL TARTRATE 75 50 24 11
MELOXICAM 73 59 25 24
GLIMEPIRIDE 69 57 26 33
CYMBALTA 67 31 27 49
RAMIPRIL 66 49 28 67
CLONIDINE HCL 63 54 29 55
TRICOR 62 50 30 83
DIGOXIN 59 54 31 48
DONEPEZIL HCL 56 56 32 30
PROPRANOLOL HCL 55 35 33 109
CITALOPRAM HBR 54 31 34 18
NIASPAN 53 53 35 103
BYSTOLIC 53 53 35 64
NAMENDA 52 52 37 35
DICLOFENAC SODIUM 52 38 37 98
JANUVIA 52 52 37 107
DOXAZOSIN MESYLATE 52 44 37 79
ADVAIR DISKUS 51 37 41 38
PREDNISONE 51 26 41 31
AVODART 50 50 43 144
RANITIDINE HCL 50 50 43 40
SYNTHROID 50 50 43 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.